Methods of treating and/or suppressing weight gain

Details for Australian Patent Application No. 2009200258 (hide)

Owner Endorecherche, Inc.

Inventors Deshaies, Yves; Martel, Celine; Labrie, Fernand; Marette, Andre; Richard, Denis

Agent Griffith Hack

Pub. Number AU-B-2009200258

Parent 2005229713

Filing date 23 January 2009

Wipo publication date 26 February 2009

Acceptance publication date 12 January 2012

International Classifications

A61K 31/00 (2006.01)

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/353 (2006.01)

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/453 (2006.01)

A61K 31/5377 (2006.01)

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61K 31/568 (2006.01) - substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone

A61K 31/5685 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

Event Publications

12 February 2009 Complete Application Filed

26 February 2009 Application Open to Public Inspection

  Published as AU-B-2009200258

12 January 2012 Application Accepted

  Published as AU-B-2009200258

10 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009200259-Biostatic medical cleaning products

2009200257-Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione